Novartis exec moves to J&J
Executive Summary
Head of Novartis' North American pharmaceuticals unit Alex Gorsky resigns, the firm announces Feb. 14. Gorsky will join Johnson & Johnson as group chairman of the firm's medical device company Ethicon. Before joining Novartis in 2004 as Chief Operating Officer and Head of General Medicines, Gorsky served as company group chairman for J&J's pharmaceutical business in Europe, the Middle East and Africa. Gorsky will report to J&J Worldwide Chairman for Surgical Care Sheri McCoy...